Amount$25M
SeriesSeries B
AnnouncedNov 30, 2022
Time since last round277 mo
SectorLife Sciences, Immunotherapy, Immunology, Cancer, Cancer Immunotherapy, Antibody
Sub-sectorArtificial Intelligence
Strong
A strong, well-structured round.
Round size vs peers
In line with the typical Series B round.
Syndicate size
Healthy syndicate of 3 investors.
Insider conviction
2 existing investors re-upped — insiders doubling down.
Investor track record
A mix of established and emerging investors.
Heuristic read of round size vs peers, syndicate size, insider conviction, and investor track record. Not investment advice.
vs. Series B rounds (996)
Round size distribution43th pct
smaller Series B roundslarger
vs. Life Sciences, Immunotherapy, Immunology, Cancer, Cancer Immunotherapy, Antibody (6)
Round size in sector100th pct
$3Mthis round: $25M$25M
